Key Updates
ASML shares fell 2.08% since the October 13 report, from $1,704.43 to $1,669.04, extending the pullback from the October high of $1,820.71 to approximately 8.3%. The decline occurred despite Q3 results that beat on profitability: EPS rose 136% YoY to EUR12.93 and net profit of EUR4.96 billion topped expectations, while revenue of EUR11.66 billion narrowly missed the EUR11.85 billion consensus. Management raised full-year 2026 sales guidance for the third time this year to EUR44-45 billion and lifted gross margin guidance to approximately 56%, alongside Q4 guidance of EUR14.2-15.2 billion in sales at ~57% margin. Reports indicate an initial 2-3% intraday pop on the earnings release, but the stock closed the day down 2.84%, suggesting the revenue miss and/or profit-taking after a 56% YTD rally outweighed the margin beat and long-term demand commentary.
Current Trend
ASML remains up 56.01% YTD despite the recent five-session slide of -7.53%, indicating a sharp but so far contained correction within a dominant uptrend. The stock is testing levels below $1,670 after failing to sustain the October high near $1,820.71, which now acts as near-term resistance. The 1-month (+5.96%) and 6-month (+9.93%) returns remain positive, confirming the medium-term trend is intact even as short-term momentum has turned negative. The divergence between strong fundamental results and negative price action signals elevated volatility and a market reassessing an already-rich valuation following the multi-quarter guidance upgrades.
Investment Thesis
The core thesis rests on ASML's monopoly position in EUV lithography, a technology for which "there is only one company making those machines," according to CEO Christophe Fouquet (FT). Structural AI-driven semiconductor capex, multi-year order visibility extending to 2029-2030, and continued capacity expansion underpin a durable, multi-year growth runway. Morningstar's EUR1,800 fair value estimate and emphasis on ASML's EUR6 billion R&D moat support a long-term bullish stance, tempered by near-term valuation and execution risk tied to the scale of capacity build-out.
Thesis Status
The fundamental thesis remains intact and arguably strengthened: three guidance raises in 2026, record EPS growth, and customer demand visibility stretching to 2030 confirm structural, not cyclical, demand. However, the Q3 revenue miss and the stock's inability to hold gains post-earnings indicate the market had priced in near-flawless execution, and any shortfall—however minor—triggers outsized downside. The thesis is shifting from a pure "beat-and-raise" momentum story toward a "priced-for-perfection" dynamic, requiring closer monitoring of execution against the 2027-2028 capacity targets (65 to 90 tools, up to 70% capacity increase by 2028) referenced in recent coverage.
Key Drivers
Key drivers behind the current move include: the Q3 revenue miss against elevated expectations despite a 55% YoY increase (Morningstar); the third consecutive 2026 guidance raise to EUR44-45 billion and margin guidance to ~56% (Morningstar); disclosure of customer orders extending to 2029-2030 and planned capacity expansion beyond the 2027 target of 90 tools (Morningstar); planned price increases effective 2027 with full impact by 2028 (Morningstar); and ongoing geopolitical risk from US-led export restrictions to China, which the CEO warned could accelerate Chinese competition (FT).
Technical Analysis
ASML has retraced approximately 8.3% from its October high of $1,820.71, with the 5-day decline of -7.53% signaling accelerated selling pressure despite positive fundamental news. The stock's failure to hold gains after the Q3 earnings beat suggests $1,820 has become a firm near-term resistance level. With the 1-day move of -2.84% following an initial post-earnings pop, the pattern resembles a "sell-the-news" reaction. YTD gains of 56.01% remain substantial, and the longer-term uptrend (6-month +9.93%) is intact, but short-term momentum has turned bearish, with the next support level untested within the provided data below current price.
Bull Case
- Irreplaceable monopoly position: ASML is the sole global producer of EUV lithography machines, critical for advanced AI chip manufacturing, reinforced by an ecosystem of 200+ principal suppliers (FT).
- Multi-year demand visibility: Customers are already placing orders for 2029 and 2030 delivery, with current 2027 capacity plans (65 to 90 tools) seen as insufficient to meet demand (Morningstar).
- Third consecutive guidance raise in 2026: FY sales guidance lifted to EUR44-45 billion and gross margin guidance improved to ~56%, with Q4 guidance of EUR14.2-15.2 billion sales at ~57% margin (Morningstar).
- Pricing power: Planned price increases take effect in 2027 with full financial impact by 2028, reflecting tight market conditions and strong negotiating leverage (Morningstar).
- Durable competitive moat: Morningstar maintains a EUR1,800 fair value estimate, citing high customer switching costs and an unmatched EUR6 billion annual R&D budget expected to sustain market leadership for at least a decade (Morningstar).
Bear Case
- Q3 revenue miss: Revenue of EUR11.66 billion fell short of the EUR11.85 billion consensus despite 55% YoY growth, indicating expectations may be outpacing even strong execution (Morningstar).
- Sell-the-news price action: Despite an EPS beat and raised guidance, shares fell 2.84% intraday and 7.53% over five days, suggesting the rally had already priced in a near-flawless quarter after a 56% YTD gain.
- Geopolitical/export risk: US-led restrictions on EUV technology exports to China risk accelerating indigenous Chinese competition, per CEO commentary, a potential long-term threat to ASML's monopoly (FT).
- Execution risk on capacity expansion: Plans to scale output by up to 70% by 2028 and expand tool capacity beyond 90 units require significant capital investment and operational scaling, introducing delivery and margin risk (Morningstar).
- Valuation stretch near fair value: With Morningstar's fair value estimate at EUR1,800 per share and the stock having appreciated 88% over the past year per CEO commentary, upside may be increasingly limited absent further upward guidance revisions (FT).